Radiation Oncology/Therapy: Page 453

CMS deals blow to gamma camera PET
By AuntMinnie.com staff writers
The U.S. agency that administers the Medicare and Medicaid programs has ruled out reimbursement for most PET studies conducted on gamma cameras rather than dedicated PET systems. The ruling is a blow to nuclear medicine advocates, who had hoped that the agency would adopt a more liberal standard when paying for PET exams.
July 9, 2001
MDS Nordion to build new cyclotron
By AuntMinnie.com staff writers
Canadian radioisotope producer MDS Nordion is planning to spend $20 million to build a new cyclotron to produce medical radioisotopes. The cyclotron will produce iodine-123 and palladium-103, and will be located at a MDS Nordion facility in Vancouver.
July 8, 2001
Panama orders autopsies of radiation accident victims
By AuntMinnie.com staff writers
The Panamanian health ministry’s special prosecutor, Cristóbal Arboleda, has ordered that any patients who die following radiation overdoses undergo an autopsy, Panamanian news agency La Prensa reported today.
July 4, 2001
P.E.T.Net opens research facility with UCLA
By AuntMinnie.com staff writers
Radiopharmaceutical manufacturer P.E.T.Net Pharmaceuticals has launched a research center for the study of molecular medicine involving PET technology.
July 3, 2001
Nomos to provide VA with IMRT
By AuntMinnie.com staff writers
Radiation therapy firm Nomos has signed a contract to provide the U.S. Department of Veterans Affairs with its intensity modulated radiation therapy (IMRT) products.
July 2, 2001
DraxImage gets clearance for palladium version of BrachySeed
By AuntMinnie.com staff writers
Radiopharmaceutical firm DraxImage has received Food and Drug Administration clearance for a palladium-103 version of its BrachySeed therapy implant.
June 27, 2001
Triple-detector PET may improve peripheral lesion sensitivity
By Erik L. Ridley
TORONTO - A triple-detector hybrid PET system can provide improvements in peripheral imaging over two-detector systems, according to research presented at the Society of Nuclear Medicine meeting.
June 27, 2001
FDG-PET predicts outcomes in early lymphoma therapy
By Eric Barnes
TORONTO - A common thread linked a string of lymphoma studies presented Tuesday at the Society of Nuclear Medicine meeting. That is, as the value of FDG-PET imaging in recurrent lymphoma staging was reaffirmed, the scans were also found to be far more prognostic after the first few rounds of chemotherapy than later in treatment.
June 26, 2001
Evolution and fusion define lung imaging progress
By Eric Barnes
TORONTO - For evaluating patients with suspected primary lung cancer, nuclear medicine has come a long way, baby. On the road from gallium and V/Q to promising new radionuclides such as depreotide, to CT fusion techniques that could finally get radiotherapy planning right, Dr. Alan Waxman sees nuclear medicine's bright spots.
June 24, 2001
Radiation therapists and medical dosimetrists give people a second chance at life
Medical progress and technological advancement have made cancer a much less deadly diagnosis. Part of the medical team that helps this change occur are radiation therapists and medical dosimetrists.
June 21, 2001
AJR review chronicles fluoroscopy-induced skin damage
By Shalmali Pal
The inability of physicians to recognize radiation-induced changes in the skin can lead to misdiagnoses and incorrect treatment, according to a review in the July American Journal of Roentgenology.
June 20, 2001
PET leader Phelps gets Kettering award
By AuntMinnie.com staff writers
The General Motors Cancer Research Foundation has awarded the Charles F. Kettering Prize to Dr. Michael Phelps.
June 20, 2001
Previous Page
Page 453 of 468
Next Page